Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 65077

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 26, 2013
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Hospira Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12

D-313-2013
Recall number
D-313-2013
Initiated
February 26, 2013
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
114,000 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Code information

Lot 05-585-EV Exp. 05/13

Distribution pattern

Nationwide and Puerto Rico

drug · product 2 of 4

Furosemide Injection, USP, 40 mg/4mL (10 mg/mL), 4 ml Single-Dose Vial, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-6102-04

D-314-2013
Recall number
D-314-2013
Initiated
February 26, 2013
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
259,050 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Code information

Lot 20-564-DK Exp. 02/14

Distribution pattern

Nationwide and Puerto Rico

drug · product 3 of 4

QUELICIN (succinylcholine chloride) Injection, USP, 200 mg (20 mg/mL) 10 mL, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, , NDC 0409-6629-02

D-315-2013
Recall number
D-315-2013
Initiated
February 26, 2013
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
139,200 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Code information

Lot 21-480-EV Exp.12/13

Distribution pattern

Nationwide and Puerto Rico

drug · product 4 of 4

Sodium Acetate Injection, USP, 40 mEq/20 ml (2 mEq/mL) 20 mL Single-Dose Fliptop, Rx only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-7299-73

D-316-2013
Recall number
D-316-2013
Initiated
February 26, 2013
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
266,900 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.

Code information

Lot 23-320-DK and 23-321-DK Exp. 11/14

Distribution pattern

Nationwide and Puerto Rico